Skip to content

DRSDewael

Active
Private limited companyfounded 2023active for 3 yearsCoupure 460, 9000 Gent, BelgiumKBO/BCE: BE 1001.626.255
Summary

DRSDewael has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €214,681 and a net result of €94,674. Equity is growing by about 77% per year across the filed financial years. Its solvency ranks better than 68% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
DRSDewaelActiveChecked score 98/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€272,727total assets 2025
Equity
€214,681
Profit
€94,674
Turnover not published (micro format)
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
  • DEWAEL SophieDirector
2025 accounts filed 31 days late
Why 98raises risk1 change of registered office in 24 monthsLast filed accounts filed 31 days late; 2 of the last 3 latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.45, cash €142,988Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 82% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100+30
equity 78.7% of total assets
Liquidity 94+20
short-term debt 19.6% · cash 52.4%
Profitability 100=
return on assets 34.7%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.4 percentage points vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: 0.1%▲ +0.1 percentage points vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.2 percentage points vs 07-2026 09-2026: 0.1%▼ -0.2 percentage points vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €21,000 on 30-day terms is acceptable
Liquidity ample (current ratio 4.45, compared with 1.63 in 2024, above the usual 1.5; short-term debt: 19.6% and cash: 52.4% of total assets), and 21.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 81% on liquidity, 80% on profitability and 87% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.45, cash €142,988
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Last filed accounts filed 31 days late; 2 of the last 3 late
NBB · filings
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 3 filings
Deviation from the deadline
2025
31 days late
2024
24 days early
2023
225 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 77 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (3 of the last 3 filed years within 195 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2023 to 2025net €94,674 ▲4.5%
  3. Liquidity more than doubledcurrent ratio 4.45

Key points

  • Positive: Equity rose in 2025from €120,007 to €214,681 ▲ 78.9% View
  • One director decidessole director in office 1 View
  • Total assets 20253 financial years filed €272,727 View

By topic

Financials

Financial year
2025
Total assets
€272,727
Profit
€94,674
Solvency
78.7%
Total assets▲ 1.5%
Net result
20232025
Go to Financials

Timeline

Events
9
Since
2023
Next accounts
by 31-07-2027
  1. 31-12-2025Equity above €200,000
  2. 22-12-2025Registered office
  3. 07-07-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
25-10-2023
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
12
Annual meeting
Last Friday of June at 20:00
Purpose
“De uitoefening van de geneeskunde,meer bepaald plastische chirurgie door de…” (deed in Dutch)
Go to Articles of association

Key facts about DRSDewael

What is the company number of DRSDewael?
1001.626.255. In Belgium the VAT number is the company number with BE in front: BE 1001.626.255.
Where is DRSDewael based?
The registered office is at Coupure 460, 9000 Gent.Company details
What does DRSDewael do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DRSDewael?
Private limited company (BV).
When was DRSDewael founded?
On 25-10-2023.
Is DRSDewael still active?
Yes, DRSDewael is an active enterprise in the KBO register.
What is the turnover of DRSDewael?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DRSDewael profitable?
In financial year 2025, DRSDewael made a profit of €94,674.
Where can I find the annual accounts of DRSDewael?
DRSDewael filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DRSDewael due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DRSDewael

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure